GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (OTCPK:WUXAY) » Definitions » Price-to-Free-Cash-Flow

WUXAY (Wuxi AppTec Co) Price-to-Free-Cash-Flow : 17.48 (As of May. 16, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Wuxi AppTec Co Price-to-Free-Cash-Flow?

As of today (2025-05-16), Wuxi AppTec Co's share price is $7.90. Wuxi AppTec Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.45. Hence, Wuxi AppTec Co's Price-to-Free-Cash-Flow Ratio for today is 17.48.

The historical rank and industry rank for Wuxi AppTec Co's Price-to-Free-Cash-Flow or its related term are showing as below:

WUXAY' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 13.53   Med: 119.77   Max: 33020
Current: 18.76

During the past 11 years, Wuxi AppTec Co's highest Price-to-Free-Cash-Flow Ratio was 33020.00. The lowest was 13.53. And the median was 119.77.

WUXAY's Price-to-Free-Cash-Flow is ranked better than
54.55% of 99 companies
in the Medical Diagnostics & Research industry
Industry Median: 22.93 vs WUXAY: 18.76

Wuxi AppTec Co's Free Cash Flow per Share for the three months ended in Mar. 2025 was $0.12. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.45.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Wuxi AppTec Co was 27.60% per year.

During the past 11 years, Wuxi AppTec Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 99.50% per year. The lowest was -46.60% per year. And the median was 14.70% per year.


Wuxi AppTec Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Wuxi AppTec Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuxi AppTec Co Price-to-Free-Cash-Flow Chart

Wuxi AppTec Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 336.13 - 389.42 27.42 18.99

Wuxi AppTec Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.01 14.15 21.61 18.99 20.58

Competitive Comparison of Wuxi AppTec Co's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, Wuxi AppTec Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuxi AppTec Co's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's Price-to-Free-Cash-Flow falls into.


;
;

Wuxi AppTec Co Price-to-Free-Cash-Flow Calculation

Wuxi AppTec Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=7.90/0.452
=17.48

Wuxi AppTec Co's Share Price of today is $7.90.
Wuxi AppTec Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.45.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Wuxi AppTec Co  (OTCPK:WUXAY) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Wuxi AppTec Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuxi AppTec Co Business Description

Address
288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.